| Patents for C07D 241 - Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings (18,673) |
|---|
| 09/18/2003 | WO2003053368A3 Chalcone derivatives and their use to treat diseases |
| 09/18/2003 | WO2002076925A3 Non-imidazole aryl alkylamines compounds as histamine h3 receptor antagonists, preparation and therapeutic uses |
| 09/18/2003 | US20030176485 Calcium receptor active compounds |
| 09/18/2003 | US20030176441 Inhibitsthe binding of eotaxin to the CCR-3 receptor and thereby provide a means of combating eosinophil induced diseases, such as asthma |
| 09/18/2003 | US20030176440 For protecting skeletal muscles against damage resulting from trauma, protecting skeletal muscles subsequent to muscle or systemic diseases, therapy of shock conditions, preserving donor tissue and organs used in transplants |
| 09/18/2003 | US20030176430 For therapy and prophylaxis of Tachykinin-mediated diseases |
| 09/18/2003 | CA2479065A1 Aminoalcohol derivatives as beta-3 adrenergic receptor agonists |
| 09/17/2003 | EP1344525A1 Aniline derivatives or salts thereof and cytokine production inhibitors containing the same |
| 09/17/2003 | EP1343775A2 Piperazine derivatives |
| 09/17/2003 | EP0984777B1 Arylsubstituted piperazines useful in the treatement of benign prostatic hyperlasia |
| 09/17/2003 | EP0754682B9 Aminostilbazole derivative and medicine |
| 09/17/2003 | CN1443170A Capsaicin receptor ligands |
| 09/16/2003 | CA2167408C Process for making hiv protease inhibitors |
| 09/16/2003 | CA2068089C Method and compositions for using non-ionic contrast agents to reduce the risk of clot formulation in diagnostic procedures |
| 09/12/2003 | WO2003074495A1 Hppars activators |
| 09/12/2003 | WO2003074476A1 Novel arylamidine derivative or salt thereof |
| 09/11/2003 | US20030171461 Process for the synthesis of amine ethers from secondary amino oxides |
| 09/11/2003 | US20030171352 Sulfonylaminocarboxylic acid N-arylamides as guanylate cyclase activators |
| 09/11/2003 | US20030168970 Luminescent element material and luminescent element comprising the same |
| 09/10/2003 | EP1341784A2 Process for making a thrombin inhibitor |
| 09/10/2003 | EP1341764A1 Ortho-substituted nitrogen-containing bisaryl compounds used as potassium channel inhibitors |
| 09/10/2003 | EP1341755A1 Carboxylic acid amide derivatives and their use in the treatment of thromboembolic diseases and tumours |
| 09/10/2003 | EP1159237B1 Method of preparing surface-active alcohols and surface-active alcoholic ethers, products obtained by said method and their use |
| 09/10/2003 | EP0998465B1 Polyhydroxyalkylpyrazine derivatives, preparation and medicines containing them |
| 09/10/2003 | CN1441805A Antitumoral analogue of Et-743 |
| 09/10/2003 | CN1441789A Piperazinedione compounds |
| 09/10/2003 | CN1441679A Compositions containing therapentically active components having enhanced solubility |
| 09/10/2003 | CN1120878C Method for coal liquefaction |
| 09/09/2003 | US6617317 Boronic ester and acid compositions |
| 09/09/2003 | CA2138026C Novel 1,4-dihydroquinoxaline-2,3-diones and uses therefor as glycine receptor antagonists |
| 09/09/2003 | CA2031480C Acetylenes disubstituted with a heteroaromatic group and a substituted phenyl group having retinoid like activity |
| 09/04/2003 | WO2003072558A2 Arylsulfone derivatives |
| 09/04/2003 | WO2003072537A2 Selective protein tyrosine phosphatatase inhibitors |
| 09/04/2003 | WO2003072535A2 Substituted hydroxyethylamines |
| 09/04/2003 | WO2003072056A2 Intranasal administration of mc4-r agonists |
| 09/04/2003 | US20030166934 Using phase transfer catalyst |
| 09/04/2003 | US20030166717 Substituted amide compound containing hydroxy and amino groups; useful for treating Alzheimer's disease and other similar diseases |
| 09/04/2003 | US20030166690 Use of compounds for decreasing activity of hormone-sensitive |
| 09/04/2003 | US20030166666 Diimino-piperazine derivatives for use as modulators of cell regulation |
| 09/04/2003 | US20030166650 E.g., 3-(2-fluorophenyl)-N-(1-(3-morpholin-4-yl)phenyl)-propyl)acrylamide; disorders responsive to opening of KCNQ potassium channels; analgesics; migraine, bipolar disorders, anticonvulsants, antiepileptic, anxiolytic agents |
| 09/04/2003 | US20030166644 Compounds and uses thereof for decreasing activity of hormone-sensitive lipase |
| 09/04/2003 | US20030166637 Amines such as 9-(4-(4-(benzothiazol-2-yl)-piperazin-1-yl)-butyl)-9H-fluorene-9-carboxylic acid (2,2,2-trifluoroethyl) amide, used as microsomal triglyceride transfer protein antagonists, to prevent atherosclerosis or hyperlipemia |
| 09/04/2003 | US20030166616 A tachykinin antagonist for used as antiinflammatory agent, antiallergic agent, analgesic, antiemetics, treating irritable colon syndrome, skin disorders |
| 09/04/2003 | CA2477607A1 Substituted hydroxyethylamines |
| 09/04/2003 | CA2476173A1 Arylsulfone derivatives |
| 09/03/2003 | EP1341403A1 Luminescent element material and luminescent element comprising the same |
| 09/03/2003 | EP1339701A1 Heteroaryl alkyl piperazine derivatives as fatty acid oxidation inhibitors |
| 09/03/2003 | EP1339696A1 Benzyl(idene)-lactams and their use as 5ht1-receptor ligands |
| 09/03/2003 | EP1339684A1 Mch antagonists and their use in the treatment of obesity |
| 09/03/2003 | EP1339673A1 Malonamide and malonamic ester derivatives with antithrombotic activity, their preparation and their use |
| 09/03/2003 | EP1070065B1 Azabicyclic 5ht1 receptor ligands |
| 09/03/2003 | CN1440414A Synthesis of cuttlefish compound |
| 09/03/2003 | CN1440383A PPARγ调制剂 PPARγ modulators |
| 09/03/2003 | CN1440281A Medicine for reducing intraocular pressure |
| 09/03/2003 | CN1439638A Preparation of tetrahydrobenzothiogenin oxidate containing antimer richfully |
| 09/02/2003 | US6613769 Tryptase inhibitors |
| 09/02/2003 | US6613743 Sulfonamide inhibitors of aspartyl protease |
| 09/02/2003 | US6613345 Conjugates of sodium channel blockers and methods of using the same |
| 08/28/2003 | WO2003070709A1 Novel phenylalanine derivative |
| 08/28/2003 | WO2003070184A2 Sodium channel blockers |
| 08/28/2003 | WO2003070182A2 Sodium channel blockers |
| 08/28/2003 | US20030162799 Squaric acid derivatives |
| 08/28/2003 | US20030162789 4-alkylpiperazine substituted phenol derivative or 4-alkylamide substituted phenols for treating neurodegerative diseases such as aging, cancer, diabetes, ischemic stroke, Parkinson's disease, dementia and Huntinton's disease |
| 08/28/2003 | US20030162786 Use of cysteine derivatives for the preparation of a medicament intended to treat pathologies which result from the formation of the heterotrimeric G protein |
| 08/28/2003 | US20030162776 Substituted 5-membered polycyclic compounds useful for selective inhibition of the coagulation cascade |
| 08/28/2003 | CA2476837A1 Sodium channel blockers |
| 08/27/2003 | EP1338592A1 Novel 2-phenylpiperazine derivatives |
| 08/27/2003 | EP1337518A1 Piperazinylpyrazines compounds as antagonists of serotonin 5-ht2 receptor |
| 08/27/2003 | EP1337251A1 Monocyclic or bicyclic carbocycles and heterocycles as factor xa inhibitors |
| 08/27/2003 | EP1337218A2 Substituted felbamate derived compounds |
| 08/27/2003 | EP1185540B1 Ruthenium dimeric complexes suitable as antimetastatic and antineoplastic agents |
| 08/27/2003 | EP0906906B1 Process for preparing optically active 2-piperazinecarboxylic acid derivatives |
| 08/27/2003 | CN1119346C Benzothiadiaxoles and derivatives |
| 08/27/2003 | CN1119336C Novel compounds with analgesic effect |
| 08/26/2003 | US6610854 Reacting (Z)-5-Fluoro-2-methyl-(4-pyridylidene)-3-(N-benzyl) indenylacetamide with hydrochloric acid to produce (Z)-5-fluoro-2-methyl-(4-pyridylidene)-3-(N-benzyl)indenylacetamide hydrochloride |
| 08/26/2003 | US6610846 Heteroaromatic glucokinase activators |
| 08/26/2003 | US6610284 Preparation for prevention and healing of inflammation affections |
| 08/21/2003 | WO2003069703A1 Electrode-active materials, electrodes made by using the same, and cells equipped with the electrodes |
| 08/21/2003 | WO2003069397A2 Controlled diffusion coefficient electrochromic materials for use in electrochromic mediums and associated electrochromic devices |
| 08/21/2003 | WO2003068759A1 Piperazine derivatives as anti-inflammatory agents |
| 08/21/2003 | WO2003018549A3 Bicyclic compounds as inhibitors of chemokine binding to us28 |
| 08/21/2003 | WO2002020463A3 Fxr modulators |
| 08/21/2003 | WO2002002512A3 Compounds to treat alzheimer's disease |
| 08/21/2003 | US20030158411 Methods for preparing 5- and 6-benzyl-functionalized quinoxalines |
| 08/21/2003 | US20030158205 N-benzyl-substituted, e.g., (2S)-1-(p-chlorophenoxy)methyl)-carbonyl-2-methyl-4-(p -fluorobenzyl)piperazine; inhibit the activity of the chemokines, MIP-1 alpha and RANTES |
| 08/21/2003 | US20030158202 Substituted fused ring sulfonamides containing, e.g., naphthalene, isoquinoline, quinoline, benzofuran or benzothiophene rings; treatment of conditions relating to obesity, type II diabetes and CNS disorders |
| 08/21/2003 | US20030158186 Compositions and methods for treating heart failure |
| 08/21/2003 | US20030158185 Novel use of phenylheteroakylamine derivatives |
| 08/21/2003 | CA2464451A1 Controlled diffusion coefficient electrochromic materials for use in electrochromic mediums and associated electrochromic devices |
| 08/20/2003 | EP1336608A1 Dibenzosberanyl piperazine derivatives and drug-resistance overcoming agents containing the derivatives |
| 08/20/2003 | EP1335907A1 Piperazinylpyrazine compounds as agonist or antagonist of serotonin 5ht-2 receptor |
| 08/20/2003 | EP1282608B1 Production of 2-ethyl-3-methyl-1,4-diazine |
| 08/20/2003 | EP1150944B1 N2-phenylamidine derivatives |
| 08/20/2003 | CN1118456C 1,2-dihydro-2-oxoquinoline derivatives |
| 08/19/2003 | US6608195 Process for the preparation of 2-(4-alkyl-1-piperazinyl)-benzaldehyde and -benzylidenyl compounds |
| 08/19/2003 | US6608067 Inhibitors of serine proteases, particularly HCV NS3 protease |
| 08/19/2003 | US6608063 For example: (2-(3-amino-4-nitrophenyl)amino)ethyl)(6-(2,4-dichlorophenyl-5-nitropyrazin -2-yl)-amine; antidiabetic, -carcingenic and ischemic agents; nervous and cardiovascular system disorders; immunotherapy; obesity; syndromes |
| 08/19/2003 | US6608060 Treating inflammatory diseases, destructive bone disorders, reperfusion/ischemia in stroke, myocardial ischemia, renal ischemia, cardiac hypertrophy, rheumatoid arthritis, inflammatory bowel disease, or Crohn's disease |
| 08/19/2003 | US6607741 Conjugates of sodium channel blockers and methods of using the same |
| 08/14/2003 | WO2003066604A2 Novel aryl- and heteroarylpiperazines |